Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹1.8 LQualified 46 1965 VAKKATTU ROAD CHAKKARAPARAMBU THAMMANAM P O ERNAKULAM KERALA 682032 | ERNAKULAM | KERALA | 682032 | L1 | Qualified |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
5 Aug 2025, 10:00 amClosed
FLUTICASONE 100mcg+ UMECLIDINIUM 62.5mcg+ VILANTEROL 25mcg MULTIDOSE DRY POWDER ELIPTA INHALER.
8125726
GEM/2025/B/6484973
Two Packet Bid
FLUTICASONE 100mcg+ UMECLIDINIUM 62.5mcg+ VILANTEROL 25mcg MULTIDOSE DRY POWDER ELIPTA INHALER.
GeM Contract
240 days
Sankar Choudhury763008Nalco Hospital, Damanjodi, Dist- Koraput
Total value wise evaluation
PRODUCT_CUSTOM
Awarded to Synergy Associates
₹1.8 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| FLUTICASONE 100mcg+ UMECLIDINIUM 62.5mcg+ VILANTEROL 25mcg MULTIDOSE DRY POWDER ELIPTA INHALER. | gsk / Trelegy Ellipta | 30043200 | 75 pieces | 2,445.37 | 183,402.75 |
3 documents required · 3 mandatory
Exempted
29 Oct 2025
26 Jul 2025
5 Aug 2025
FLUTICASONE 100mcg+ UMECLIDINIUM 62.5mcg+ VILANTEROL 25mcg MULTIDOSE DRY POWDER ELIPTA INHALER. | Brand:gsk | Model:Trelegy Ellipta | HSN:30043200 | Qty:75 pieces | UnitPrice:2,445.37 | Amount:183,402.75
contract_GEMC-511687795798354.pdf
GEM_CONTRACT • 0.08 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8125726.pdf
GEM_BID
6000063705_2025-07-23-10-11-24_c9861d8065804e0312b9dd6675d2a412.pdf
SPECIFICATION
41c2cdaf01f86c46d58c8044acb0e914.pdf
OTHER
SA8000Med_1a607f84-31fc-4621-84d91753246304687_ahemanth.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .